The development and assay performance of a direct kinetic fluorimetric assay for angiotensin-converting enzyme is described. It is based on the substrate developed by Carmel et al. (Clin Chim Acta 1979; 93: 215-20), and applied to a microcentrifugal analyser with fluorescence optics. The method is sufficiently sensitive and precise to detect both normal and pathological activities; the method is linear up to at least three times the upper limit of the reference range. The method correlates well with an established method. Because of interference, the method is unsuitable for use with icteric or haemolysed samples.
The measurement of angiotensin-converting enzyme (ACE, peptidyl dipeptidase, EC 3.4.15.1) activity in serum is important in the diagnosis and management of sarcoidosis. 1 Methods for its analysis in serum have used the natural substrate, angiotensin-l ," or substrate analogues.r" The majority of methods consist of an incubation for a fixed interval in the presence of substrate followed by a chemical reaction to detect the product formed. In general, kinetic enzyme assays (in which the enzyme reaction is monitored continuously) are superior" and more readily automated. However, they require that the product (or substrate) be detectable in the conditions used during the incubation. Recently Carmel et al.' described a fixed interval method for measuring ACE activity using o-amino-benzoylglycylp-nitro-L-phenylalanyl-L-proline [ABz-Gly-Phe(NOz}-Pro] as substrate. Cleavage of this substrate by ACE releases the fluorescent o-aminobenzoylglycine (ABz-Gly). The development and assay performance of a kinetic method using this substrate is described. The analyses were performed on a microcentrifugal analyser with direct monitoring of the fluorescent product.
Materials and methods

REAGENTS
ABz-Gly-Phe(NOz}-Pro and ABz-Gly were Correspondence 
WORKING ASSAY REAGENT
ABz-Gly-Phe(NOz}-Pro, 14 mg, is dissolved in 0·4 mL of methanol and added to 1·21 g of Tris, 4·5 g of NaCl, 0·4 ml of cone, HCI in about 40 mL of water. The pH is adjusted to 8·2 and the total volume made up to 50 mL with water. This assay reagent contains per litre 0·59 mmol of ABz-Gly-Phe(NOz}-Pro, 0·2 mol of Tris, pH 8,2, and 1·5 mol of NaCI. It is stable for at least 1 month at 4°C. ENZYME ASSAY Human serum samples were used without any pretreatment. The serum, 30 I-lL, was mixed with 120 I-lL of working assay reagent (total volume 170 !J.L, including 10 !J.L wash volume for sample and reagent) and incubated at 37°C. The fluorescence (excitation wavelength 350 nm, emission wavelength 415 nm) was measured 1 minute after mixing and every 2 minutes for 24 minutes.
For all assays we used an IL FLS Multistat III microcentrifugal analyser [Instrumentation Laboratory (UK) Ltd, Warrington, UK].
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CALCULATION OF ENZYME ACTIVITY
Simultaneously with the monitoring of the enzyme activity the fluorescence of water and 10 IJ,moVL of quinine bisulphate (OBS) is measured. The OBS and water are placed in cuvettes 1 and 2, respectively, in the analyser rotor. The fluorescence of 10 IJ,moVL OBS under assay conditions is equal to that of 46 IJ,moVL of ABz-Gly (see Results section).
The fluorescence of ABz-Gly was lower in the presence of substrate ( Fig. 1 ). This was presumably due to absorption of the exciting light by the substrate. The absorbance (1 em) of 0·42 mmollL substrate was 0·5.
PH OPTIMUM
The pH optimum of the ACE in human serum at a substrate concentration in the assay of 0·42 mrnol/L was 8·2. At 0·21 rnmol/L substrate concentration, however, the pH optimum was about 0·4 pH units lower (Fig. 2 ). fluorescence of 10 IJ,moVL OBS -water blank x total volume x 46 sample volume
Results
STAN DARDISATION
To standardise the assay the fluorescence of increasing concentrations of ABz-Gly in the presence of several different concentrations of substrate was compared with that of 10 IJ,moVL of OBS (Fig. 1 ). The fluorescence was measured using the microcentrifugal analyser with excitation at 350 nm and the emission filter was 415 nm. The band-pass of the excitation light is not adjustable and is about 32 nm. The bandpass of the emission filter is about 10 nm. It was found that 10 urnol/L of OBS was equivalent to 46 umol/L of ABz-Gly. When using a Perkin Elmer model MPF-34 fluorimeter (excitation 360 nm, slit width 8 nm; excitation 410 nm, slit width 10 nm), the fluorescence of 10 IJ,moVL OBS was equivalent to 46 IJ,moVL ABz-Gly.
SUBSTRATE OPTIMUM
In general, for accurate measurement of enzyme activity it is desirable to use a substrate concentration several-fold greater than the K m of the substrate for the enzyme. At such a concentration the activity does not change with small changes in substrate concentration. In order to determine the K m accurately, it is necessary to use substrate concentrations in excess of the K m . Initial experiments were undertaken using concentrations in the assay from 0·05 to 0·42 mrnol/L; the value for the K m obtained from linear Lineweaver-Burk plots was 0·4 ± 0·10 mrnol/L (mean ± SEM using three serum samples). It was not possible to make accurate activity measurements at higher substrate concentrations due to the reduction in fluorescence intensity ( substrate concentration of 0·42 mmol/L was chosen as the substrate concentration for the assay as it yielded the maximum signal.
EFFECT OF CHLORIDE ION
Chloride caused activation of ACE in human serum; the optimum concentration was equivalent to 1·0 mol/L in the assay (Fig. 4 ).
EFFECTS OF METAL IONS AND INHIBITORS
Of several metal ions only addition of zinc to enzyme inhibited by EDTA fully restored the activity. However, addition of zinc to the assay (in the absence of EDTA) did not enhance the activity (Table I) . The enzyme was sensitive to inhibition by low levels of the so-called specific ACE inhibitors, captopril and teprotide (Table 1) . product at these substrate concentrations, an estimate of the true activity can be made ( Fig.  3 , open circles). The shape of this curve is consistent with a K m of 0·4 mmol/L but transformation of these data did not yield a linear Lineweaver-Burk plot.
The effect of substrate concentration on the rate of change of fluorescence is illustrated in Fig. 3 (filled circles) . At low substrate concentrations the rate increases with respect to substrate concentration, in accordance with Michaelis-Menten kinetics, but decreases at high substrate concentrations, presumably due to a reduced excitation of the product in the presence of high substrate concentrations. A After estimating the variation of the reagent blank the detection limit (three times the standard deviation of the reagent blank variation) was determined as 0·38 nmol/min/mL. LINEARITY The assay was found to be linear with respect to enzyme activity up to at least 12 nmol/min/mL (Fig. 5 ). This was the highest activity found in the patients' samples studied. PRECISION Within-and between-batch precision was assessed at three levels of activity. Betweenbatch precision was assessed over a period of 14 days. The results are shown in Table 2 .
REFERENCE RANGE
Fifty samples from blood donors were analysed.
The mean ± SD was 2·62 ± 0·74 nmol/min/mL. The reference range calculated as the mean ± 2 SD was found to be from 1·14 to 4·10 nmol/min/ mL. The ACE activity of 66 patients' samples were analysed by the method of Friedland and Silverstein and the method described. The results are shown in Figure 6 .
INTERFERENCES
The assay of enzyme activity was found to be sensitive to interference by bilirubin (50% apparent inhibition at 40 IJ.moUL) and haemolysis (50% apparent inhibition at 1% haemolysis, equivalent to 0·15 gIL of haemoglobin), but not by lipaemia (triglyceride > 6 mmol/L). The interference was thought to be due to quenching of the fluorescence of the product as addition of these substances to ABz-Gly (in the presence of substrate with enzyme absent) led to a reduction in the fluorescence of the ABz-Gly equal to the interference observed in the assay.
Discussion
The kinetic fluorimetric method described here for measuring ACE is specific, technically simple, fast and uses a single stable reagent. It performs well in terms of precision, detection limit and linearity and correlates well with an established method. However, interference by bilirubin and haernolysis limits its usefulness to non-haernolysed and non-icteric samples. The specificity of this assay for ACE is demonstrated by inhibition with low levels of the specific ACE inhibitors, captopril and teprotide. Complete inhibition was found at concentrations which have been reported to give only 50% inhibition.!" The pH optimum of 8·2 is similar to those reported by others. 2 -7 • 9. 11 The optimum chloride concentration (1·0 mol/L in the assay) is higher than that found using other substrates. Cushman and Cheung using rabbit lung ACE and hippuryl-Lhistidy-L-leucine as substrate found that 0·3 rnol/L was the optimum chloride concentration, as did Ronca-Testoni using human serum and furylacryloyl-L-phenylalanylglycylglycine as substrate. 11 Our results agree with those of Carmel and Yaron'? who, using the same substrate as used here, found that the activity in human serum was greater in 1 rnol/L than in 0·25 rnol/L chloride.
Zinc and magnesium ions reactivated EDTAtreated enzyme to 100% and 25% respectively, in agreement with the finding of Cushman and Cheung.r' Cobalt ions restored only 50% of the activity in contrast to the results of Cushman and Cheung where cobalt reactivated the enzyme to the extent of 160%. This difference may be due to the difference in experimental design. We added metal ions in excess of EDTA, whereas Cushman and Cheung dialysed away the EDTA. Nickel and cobalt ions inhibited the native enzyme by 97% and 55%, in agreement with the findings of Ronca-Testoni.!' Copper ions inhibit the enzyme by 90% as was also found by Friedland and Silverstein. 4 The activity of ACE measured using this substrate is only 6% of that found using the method of Friedland and Silverstein (Fig. 6 ). The activity in healthy individuals was similar to that found by Carmel et al.') We found the mean ± SD to be 2·62 ± 0·74 nmol/min/ml.; Carmel et al. found it to be 2·56 ± 0·81 nmol/rnin/rnl..
Carmel and Yaron'? who developed the substrate used in this study did not use a kinetic assay for ACE measurement in human serum for two reasons: (i) the low activity of ACE in serum using this substrate requires a long incubation period (15-45 minutes) which in some kinetic analysers would lead to unacceptably long assay times and low sample throughput; (ii) the absorbance of the substrate at the concentration used in the assay is higher than the limit above which fluorescence is linearly related to concentration. The method described here overcomes the first problem because use of the centrifugal analyser with simultaneous monitoring of many cuvettes allows a long incubation time, with reasonable throughput of specimens.
The problem of non-linearity of fluorescence with respect to product concentration in the presence of substrate was not encountered (Fig.  1) . With conventional fluorogenic substrates only the product and not the substrate absorbs at the excitation wavelength, and therefore a high absorbance usually indicates a high concentration of fluorescent product. With the intra-molecularly quenched substrate used here, both substrate and product absorb at the excitation wavelength, but only the product fluoresces. Therefore, high absorbance does not necessarily indicate high product concentration.
The relationship between fluorescence and high concentrations of fluorescent molecules is complex. Non-linearity is caused by several factors.':' one of which is the 'inner cell' effect. This is the absorption of excitating light by those molecules nearest the light source, reducing the amount of light reaching the further molecules. Thus, at high concentrations of fluorescent molecules (absorbance > 0'1) a lower proportion of molecules can be excited. However, if the absorbance of the solution is not due to fluorescent molecules, the situation is different. If increasing concentrations of fluorescent molecules are added to a solution of high absorbance such that the absorbance of the solution does not change by more than 0·1, then the same proportion of molecules can be excited at each concentration. The fluorescence is linearly related to concentration despite the high initial absorbance. The fluorescence intensity, however, is reduced ( Fig. 1) . A necessary (but not sufficient) condition for linearity is that the absorbance of the fluorescent molecules must not change by more than 0·1; the total absorbance of the solution is relevant only in so far as it affects the efficiency of fluorescence, not its linearity.
The use of kinetic assays with fluorescence monitoring for serum enzymes has. not found wide acceptance because of the presence in serum of substances which quench fluorescence. The advantage in terms of simplicity and speed of the method for ACE measurement described here outweigh the limitations of using non-icteric and non-haemolysed samples. The excellent correlation with the method of Friedland and Silverstein (Fig. 6 ) indicates that these limitations would not be a major practical problem.
